Noah Davidsohn

Dr. Noah Davidsohn is the Co-Founder and Chief Scientific Officer (CSO) of Rejuvenate Bio, a pioneering gene therapy company focused on developing novel, system-wide therapies for chronic age-related disorders. An expert in translating age-reversal research, Dr. Davidsohn utilizes cutting-edge technologies like recombinant DNA, genetic therapies, and viral vector production to extend the healthspan of both animals and humans. Rejuvenate Bio was launched out of the George Church lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering, and their core approach involves a multi-gene therapy strategy to target the underlying root cause of multiple age-related conditions simultaneously. His groundbreaking research, which includes using gene therapy-mediated partial reprogramming (Yamanaka factors), has demonstrated the ability to significantly extend the remaining lifespan of extremely old mice and reverse age-related changes in tissues. The company is acti